Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07419048Recruiting
AI vs. human for hydration check
This study uses an ultrasound method to check your hydration status, comparing artificial intelligence (computer analysis) with a human expert. It aims to see if AI can accurately assess how hydrated you are.
BaselAges 18 years+ - NCT07363057RecruitingPhase 2
Study of GI-102 and GIB-7 for aging in healthy adults and cancer survivors
This trial tests whether a combination of two drugs, GI-102 and GIB-7, can affect markers of aging in healthy people and in people who have had cancer. It aims to see if these drugs might help slow or improve aging-related changes.
Charlestown, New South WalesAges 18–80 - NCT06583590RecruitingPhase 2/Phase 3
Botulinum toxin plus daily tadalafil for erectile dysfunction
This trial tests if combining two treatments—a botulinum toxin injection and a daily oral medication (tadalafil)—can help men with diabetes-related erectile dysfunction who haven't responded well to standard pills. The goal is to see if this combination improves erections better than either treatment alone.
Aswān, Aswan GovernorateAges 21 years+ - NCT06582641Recruiting
Peer Group Connection for Middle School Students
This study tests a program called Peer Group Connection to help students adjust to middle school. If your school is participating, you may be asked to join a group and fill out surveys to see if the program helps with the transition.
New Orleans, LouisianaAges 11–14 - NCT07413042RecruitingPhase 1
Radiation drug combined with immunotherapy for extensive-stage small cell lung cancer
This trial tests a combination of a radioactive drug ([225Ac]Ac-DOTATATE) and an immunotherapy drug (Tislelizumab) as maintenance treatment for people with extensive-stage small cell lung cancer (ES-SCLC) whose tumors have a specific protein (SSTR). If you have completed first-line treatment and your cancer shows SSTR on a PET scan, this study may be an option.
Beijing, Beijing MunicipalityAges 18–80 - NCT07062146Recruiting
Reiki for pain after back fusion surgery
This study tests whether Reiki (a gentle hands-on energy therapy) can help reduce pain after lower back fusion surgery. It aims to see if adding Reiki to standard care improves recovery.
ParisAges 18–75 - NCT05865652Recruiting
7T brain scan study for teens at risk of psychosis
This trial tests how the brain’s cell membranes and energy use look in teens who are at high risk of developing psychosis. It compares them with healthy teens to better understand early brain changes that might help future care.
PoitiersAges 15–25 - NCT05877963RecruitingPhase 3
Ublituximab treatment plan for relapsing multiple sclerosis
This Phase 3 trial tests the safety and effectiveness of a modified treatment plan using ublituximab for relapsing multiple sclerosis. It also studies how the drug behaves in the body and aims to improve disease control while monitoring side effects.
Birmingham, AlabamaAges 18–65 - NCT07410156Recruiting
Comparing treatments for dark gums
This trial tests a new technique using tiny needles and a plant extract (silymarin) to lighten dark gums, and compares it to laser and scalpel methods.
Al FayyumAges 18 years+ - NCT07425522RecruitingPhase 1
Testing a new eye injection for diabetic macular edema
This study tests a new drug (RO7823653) given as an eye injection for people with diabetic macular edema, a condition where swelling in the retina harms vision. It aims to see if the drug is safe and how the body processes it.
Peoria, ArizonaAges 18 years+ - NCT06845163RecruitingPhase 2
Testing dapagliflozin for diabetic macular edema
This study tests whether a medication called dapagliflozin, which is usually used for diabetes and heart failure, can help reduce swelling in the retina (diabetic macular edema) and improve vision. It is for people with type 2 diabetes who are already taking insulin and metformin.
Alexandria, Alexandria GovernorateAges 18–85 - NCT06435663Recruiting
ultramicro-flow technique for focused ultrasound treatment of uterine tumors
This study tests a new imaging tool (ultramicro-flow technique) to help doctors treat uterine fibroids or adenomyosis with focused ultrasound without surgery. The goal is to make the treatment safer and more accurate, especially for tumors deep inside the uterus.
Yiwu, ZhejiangAges 18–50 - NCT07402876RecruitingPhase 3
Trial for primary vitreoretinal lymphoma treatment
This trial tests a treatment for primary vitreoretinal lymphoma, a rare eye cancer. It aims to see if the drug methotrexate can help patients with this condition.
Miami, FloridaAges 21 years+ - NCT07402681Recruiting
Tracking change in teens after trauma with weekly therapy
This study tests a type of talk therapy (TF-CBT) for teens who have been through trauma and still have upsetting symptoms like nightmares, flashbacks, or strong anxiety. It focuses on tracking how symptoms change over time and offers weekly sessions with a supportive adult.
Zurich, Canton of ZurichAges 12–18 - NCT07399093Recruiting
Ultrasound test before brain surgery anesthesia
This trial uses ultrasound to measure blood flow and fluid levels in the body before brain surgery. It aims to help doctors manage fluids better during and after anesthesia.
CairoAges 18–40 - NCT07398222Recruiting
Stomach contents in tirzepatide users and fasting volunteers
This study uses an ultrasound to look at the stomach contents of people who are taking tirzepatide compared to those who are not. It will help doctors understand how this medication affects stomach emptying during fasting.
São Paulo, São PauloAges 18 years+ - NCT06260683Recruiting
Comparing tobacco vs. non-tobacco flavored e-cigarettes for quitting smoking
This study tests whether using e-cigarettes with a tobacco flavor or a non-tobacco flavor helps people who smoke switch away from regular cigarettes. Participants will use either e-cigarettes or nicotine replacement therapy for a period of time, and researchers will track their smoking behavior.
Columbus, OhioAges 21 years+ - NCT06900010RecruitingPhase 2
CM336 for Autoimmune Blistering Disease
This study tests a new drug called CM336 for people with autoimmune blistering diseases. The drug is designed to calm the immune system and reduce blistering, aiming to improve skin health.
JinanAges 18 years+ - NCT06923267Recruiting
Ultrasound to check heart function during breathing trials
This trial tests if using ultrasound to monitor your heart during a breathing test can help predict if you will need the breathing tube again. It is for people on a ventilator for at least 24 hours who are at higher risk of needing the tube reinserted.
OrléansAges 18 years+ - NCT06780540Recruiting
Testing a tool to help victims of violence in hospitals
This study tests a psychoeducation tool and a guideline designed to help hospital staff support victims of violence (including older adults). The goal is to see if these tools work well and are helpful for both patients and healthcare providers.
AntwerpAges 16 years+ - NCT07389863Recruiting
Sexual health after rectal cancer treatment
This study looks at the long-term effects of rectal cancer treatment on gynecological and sexual health. It aims to understand how women recover after treatment, helping improve future care and support.
RouenAges 18–60 - NCT06347263Recruiting
Gum surgery technique for deep pockets between teeth
This trial tests a surgical technique to treat deep gum pockets between teeth. It compares using a special gum-saving method alone, with a bone graft, or with a platelet-rich fibrin injection to see which helps heal the bone best.
CairoAges 18–50 - NCT07151898Recruiting
PET/CT scan to see if a new drug is working in advanced lung cancer
This trial tests whether a special PET/CT scan can show how well a Trop2-targeting drug is working in people with advanced lung cancer that has already been treated. It aims to improve how we monitor treatment response.
Xiamen, FujianAges 18 years+ - NCT06414278Recruiting
Spotting early thinking and memory changes with immunotherapy
This study looks at how a special type of immunotherapy called CAR-T therapy might affect your thinking skills, memory, and ability to focus. By checking on patients early and often, the team hopes to find simple ways to detect and manage these side effects sooner.
Minneapolis, MinnesotaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.